Fulvestrant and male breast cancer: a pooled analysis

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

(2014) F. Cardoso et al.   ANNALS OF ONCOLOGY

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

(2014) F. Cardoso et al.   BREAST

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

(2013) F Zagouri et al.   BRITISH JOURNAL OF CANCER

Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial

(2013) A. D. Leo et al.   JNCI-Journal of the National Cancer Institute

Fulvestrant and male breast cancer: a case series

(2012) F. Zagouri et al.   ANNALS OF ONCOLOGY

Fulvestrant for advanced male breast cancer patients: a case series

(2011) G. Masci et al.   ANNALS OF ONCOLOGY

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

(2011) Suleiman Massarweh et al.   BREAST CANCER RESEARCH AND TREATMENT

Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer

(2011) H. M. Linden et al.   CLINICAL CANCER RESEARCH

Male breast cancer: An update in diagnosis, treatment and molecular profiling

(2010) Susan Onami et al.   MATURITAS

Fulvestrant in advanced male breast cancer

(2009) J. R. de la Haba Rodriguez et al.   ANNALS OF ONCOLOGY

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Evaluation of Risk Factors for Male Breast Cancer

(2008) L. A. Brinton et al.   JNCI-Journal of the National Cancer Institute